Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans.
D001162:Arteriosclerosis Obliterans / Q000097:blood* / Q000188:drug therapy; D001792:Blood Platelets / Q000187:drug effects; D011464:Epoprostenol / Q000494:pharmacology*; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology*
D011453:Prostaglandins; D011464:Epoprostenol